Page last updated: 2024-10-22

amitriptyline and Age-Related Macular Degeneration

amitriptyline has been researched along with Age-Related Macular Degeneration in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research Excerpts

ExcerptRelevanceReference
"Thus, we quantified the risk of maculopathy with PPS with a focus on risk with duration of use."1.72Risk of maculopathy with pentosan polysulfate sodium use. ( Bae, SS; Etminan, M; Kezouh, A; Maberley, D; Sodhi, M, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bae, SS1
Sodhi, M1
Maberley, D1
Kezouh, A1
Etminan, M1

Other Studies

1 other study available for amitriptyline and Age-Related Macular Degeneration

ArticleYear
Risk of maculopathy with pentosan polysulfate sodium use.
    British journal of clinical pharmacology, 2022, Volume: 88, Issue:7

    Topics: Amitriptyline; Cystitis, Interstitial; Humans; Macular Degeneration; Pentosan Sulfuric Polyester; Re

2022